undefined undefined - EuroIntervention

Showing 1-9 of 9 articles

Treatment with a dedicated bifurcation sirolimus-eluting cobalt-chromium stent for distal left main coronary artery disease: rationale and design of the POLBOS LM study

Asano T, Kogame N, Onuma Y, Modolo R, Chichareon P, Lefèvre T, Legutko J, Digne F, Morel M, Serruys PW, Gil R

October 23, 2020 | 10.4244/EIJ-D-19-00361

Regular drug-eluting stents versus dedicated bifurcation drug-eluting BiOSS stents for coronary bifurcation treatment: four-year results of the randomised POLBOS I and POLBOS II clinical trials

Gil R, Bil J, Kern A, Ingio Garcia L, Formuszewicz R, Dobrzycki S, Vassilev D, Segiet A

March 20, 2020 | 10.4244/EIJ-D-18-00172

Intracoronary electrocardiogram to guide percutaneous interventions in coronary bifurcations – a proof of concept: the FIESTA (Ffr vs. IcEcgSTA) study

Vassilev D, Dosev L, Collet C, Karamfiloff K, Stoikova J, Pancheva R, Shumkova M, Zlatancheva G, Naunov V, Rigatelli G, Kassab G, Gil R, Serruys PW

August 3, 2018 | 10.4244/EIJ-D-17-00189

Coronary interventions

Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial

Gil R, Bil J, Grundeken M.J, Kern A, Iñigo Garcia L, Vassilev D, Pawłowski T, Formuszewicz R, Dobrzycki S, Wykrzykowska J, Serruys PW

December 9, 2016 | 10.4244/EIJY15M11_11

Coronary interventions

Long-term effectiveness and safety of the sirolimus-eluting BiOSS LIM® dedicated bifurcation stent in the treatment of distal left main stenosis: an international registry

Gil R, Bil J, Grundeken M.J, Iñigo Garcia L, Vassilev D, Kern A, Pawłowski T, Wykrzykowska J, Serruys PW

November 20, 2016 | 10.4244/EIJY15M10_05

Coronary interventions

Dedicated stents for distal left main stenting

Grundeken M.J, Magro M, Gil R, Briguori C, Sardella G, Berland J, Wykrzykowska J, Serruys PW

May 19, 2015 | 10.4244/EIJV11SVA29

Coronary interventions

The BiOSS stent

Gil R, Bil J, Vassilev D

May 19, 2015 | 10.4244/EIJV11SVA37

Dedicated paclitaxel-eluting bifurcation stent BiOSS® (bifurcation optimisation stent system): 12-month results from a prospective registry of consecutive all-comers population

Gil R, Vassilev D, Michalek A, Kern A, Formuszewicz R, Dobrzycki S, Wójcik J, Lesiak M, Kardaszewicz P, Lekston A

July 27, 2012 | 10.4244/EIJV8I3A50

Bifurcation Optimisation Stent System (BiOSS Lim) with sirolimus elution: results from porcine coronary artery model

Vassilev D, Gil R, Milewski K

September 30, 2011 | 10.4244/EIJV7I5A98

1

Latest news

State-of-the-Art on Coronary Physiology; a Mini Focus on Biostatistics; Post-TAVI Aortic Manipulation; Minimally Invasive Ventricular Reconstruction after MI

EBC 15th consensus document

Save the date: 19th April at 6pm (CET). Join us on Twitter for the 2nd edition

This Week's JAA's: Deep Learning Model to Detect AMI, Mortality After Bleeding vs MI in CAD Patients...

New update: EXAMINATION 10 years, BIONYX 2 years, SAFE A, MASH and more

(Thanks to the support of Biotronik)

Randomised Comparison between POT and KBT: PROPOT Trial

Yusuke Watanabe et al.

Similar long-term outcome of dissimilar drug-eluting stents: is it time to change the assessment?

Clemens von Birgelen et al.

Optimising Physiological Endpoints of Percutaneous Coronary Intervention

Valvular disease